1. Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method
    Mehdi Birjandi et al, 2016, Iran Red Crescent Med J CrossRef
  2. Increased Hepatic Fatty Acids Uptake and Oxidation by LRPPRC-Driven Oxidative Phosphorylation Reduces Blood Lipid Levels
    Shi Lei et al, 2016, Front. Physiol. CrossRef
  3. Fatty liver indexvswaist circumference for predicting non-alcoholic fatty liver disease
    Nima Motamed et al, 2016, WJG CrossRef
  4. Interval increase in the prevalence of symptomatic cholelithiasis-associated non-alcoholic fatty liver disease over a ten-year period in an Asian population
    KB Khaw et al, 2017, smedj CrossRef
  5. Association between colon diverticula and hemoglobin, triglyceride and uric acid levels
    MINORU TOMIZAWA et al, 2015 CrossRef
  6. Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)
    Zahra Dehnavi et al, 2018, Hepat Mon CrossRef
  7. A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression
    Sajida Perveen et al, 2018, Sci Rep CrossRef
  8. Enzymatic extract from Ecklonia cava : Acute and subchronic oral toxicity and genotoxicity studies
    Jun-Won Yun et al, 2018, Regulatory Toxicology and Pharmacology CrossRef
  9. In vitro and in vivo safety studies of cinnamon extract ( Cinnamomum cassia ) on general and genetic toxicology
    Jun-Won Yun et al, 2018, Regulatory Toxicology and Pharmacology CrossRef
  10. Galactomannan More than Pectin Exacerbates Liver Injury in Mice Fed with High-Fat, High-Cholesterol Diet
    Miriam G. Shtriker et al, 2018, Mol. Nutr. Food Res. CrossRef
  11. Lipid- and gut microbiota-modulating effects of graphene oxide nanoparticles in high-fat diet-induced hyperlipidemic mice
    Juan Li et al, 2018, RSC Adv. CrossRef
  12. Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats
    Jun-Won Yun et al, 2018, BMC Complement Altern Med CrossRef
  13. Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey: comment
    Shih-Wei Lai, 2018, Intern Emerg Med CrossRef
  14. Serotonin signals through a gut-liver axis to regulate hepatic steatosis
    Wonsuk Choi et al, 2018, Nat Commun CrossRef
  15. Preclinical study of safety of Dendropanax morbifera Leveille leaf extract: General and genetic toxicology.
    Jun-Won Yun et al, 2019, J Ethnopharmacol CrossRef
  16. Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis
    Qian Wang et al, 2015, Sci Rep CrossRef
  17. Metabolic Characteristics of a Novel Ultrasound Quantitative Diagnostic Index for Nonalcoholic Fatty Liver Disease
    Yin-Yin Liao et al, 2019, Sci Rep CrossRef
  18. Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice
    Sophie A.H. Jacobs et al, 2019, Nutrients CrossRef
  19. Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study
    Yukiko Fukuda et al, 2016, Liver Int CrossRef
  20. Comprehensive Analysis of the Safety Profile of a Single-Stranded RNA Nano-Structure Adjuvant
    Hyeong-Jun Park et al, 2019, Pharmaceutics CrossRef
  21. Exacerbations of oral lichen planus and elevated levels of aminotransferases
    Gian P. Bombeccari et al, 2017, Int J Dermatol CrossRef
  22. A comprehensive study on in vitro and in vivo toxicological evaluation of Artemisia capillaris
    Jun-Won Yun et al, 2017, Regulatory Toxicology and Pharmacology CrossRef
  23. Absence of subchronic oral toxicity and genotoxicity of rice koji with Aspergillus terreus
    Jun-Won Yun et al, 2017, Regulatory Toxicology and Pharmacology CrossRef
  24. Modeling the natural history of fatty liver using lifestyle–related risk factors: Effects of body mass index (BMI) on the life–course of fatty liver
    Mika Aizawa et al, 2019, PLoS ONE CrossRef
  25. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Obese and Overweight Children in the Northwest of Iran
    Shahsanam Gheibi et al, 2019, Hepat Mon CrossRef
  26. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
    Mohammad Abolfathi et al, 2019, Complementary Therapies in Medicine CrossRef
  27. Work Up of Fatty Liver by Primary Care Physicians, Review
    Rishi Rikhi et al, 2020, Annals of Medicine and Surgery CrossRef
  28. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity
    Rashdan Zaki Mohamed et al, 2020 CrossRef
  29. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
    Xuefeng Ma et al, 2020, BMC Gastroenterol CrossRef
  30. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease
    Kinya Okamoto et al, 2020, PLoS ONE CrossRef
  31. Common and Unique Factors and the Bidirectional Relationship Between Chronic Kidney Disease and Nonalcoholic Fatty Liver in Type 2 Diabetes Patients

    Yau-Jiunn Lee et al, 2020, DMSO CrossRef
  32. Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis
    Wenqian Fang et al, 2020, Translational Research CrossRef
  33. Skate cartilage extracts containing chondroitin sulfate ameliorates hyperlipidemia-induced inflammation and oxidative stress in high cholesterol diet-fed LDL receptor knockout mice in comparison with shark chondroitin sulfate
    Bo Gyeong Seol et al, 2020, Nutr Res Pract CrossRef
  34. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
    Hideki Fujii et al, 2020, BMC Gastroenterol CrossRef
  35. Association of the NCAN-TM6SF2-CILP2-PBX4-SUGP1-MAU2 SNPs and gene-gene and gene-environment interactions with serum lipid levels
    Guo-Xiong Deng et al, 2020, Aging CrossRef
  36. Lactobacillus Strains Alleviated Hyperlipidemia and Liver Steatosis in Aging Rats via Activation of AMPK
    Lee-Ching Lew et al, 2020, IJMS CrossRef
  37. Plasticity of gut and metabolic limitations of Deoni calves in comparison to crossbred calves on a high plane of nutrition
    Ajay Singh et al, 2020, Trop Anim Health Prod CrossRef
  38. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome
    Masahiro Sogabe et al, 2020, PLoS ONE CrossRef
  39. Involvement of HO-1 and Autophagy in the Protective Effect of Magnolol in Hepatic Steatosis-Induced NLRP3 Inflammasome Activation In Vivo and In Vitro
    Ni-Chun Kuo et al, 2020, Antioxidants CrossRef
  40. Effect of short-term oral supplementation of crocin on age-related oxidative stress, cholinergic, and mitochondrial dysfunction in rat cerebral cortex
    V.K.D. Krishnaswamy et al, 2020, Life Sciences CrossRef
  41. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Mohammad E Khamseh et al, 2021, Metab Syndr Relat Disord CrossRef
  42. Mean and visit‐to‐visit variability of glycated hemoglobin, and the risk of non‐alcoholic fatty liver disease
    Jee Hee Yoo et al, 2020, J Diabetes Investig CrossRef
  43. Food Insecurity and Lipid Profile Abnormalities Are Associated with an Increased Risk of Nonalcoholic Fatty Liver Disease (NAFLD): A Case–Control Study
    Helda Tutunchi et al, 2021, Ecology of Food and Nutrition CrossRef
  44. Association between Triglyceride Glucose Index and Corrected QT Prolongation in Chinese Male Steelworkers
    Thung-Lip Lee et al, 2021, IJERPH CrossRef
  45. Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease
    Elizabeth M. Lamos et al, 2021, Expert Review of Clinical Pharmacology CrossRef
  46. Case Report of a Patient Diagnosed with Fatty Liver Accompanied by Hypertriglyceridemia
    Soyoung Hur et al, 2021, J Int Korean Med CrossRef
  47. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus
    Mojtaba Malek et al, 2021, Endocrine CrossRef
  48. Chicken Oil as The New Cooking Oil : Its Effect on Lipid Profile and Liver Histology in Male Wistar Rats
    Andi Asda Astiah et al, 2021, AMNT CrossRef
  49. The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity
    Sana Mansoor et al, 2021, Pediatr Gastroenterol Hepatol Nutr CrossRef
  50. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico
    Yvonne N. Flores et al, 2021, Lipids Health Dis CrossRef
  51. Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis
    Alexa M. Giammarino et al, 2021, Hepatol Commun CrossRef
  52. Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers
    Roshan Shafiha et al, 2021, Biomedicines CrossRef
  53. Self-nanoemulsifying composition containing curcumin, quercetin, Ganoderma lucidum extract powder and probiotics for effective treatment of type 2 diabetes mellitus in streptozotocin induced rats
    Rubiya Khursheed et al, 2021, International Journal of Pharmaceutics CrossRef
  54. Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study
    Yuling Xing et al, 2022, DMSO CrossRef
  55. Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population
    Md Asadullah et al, 2022, PLoS ONE CrossRef
  56. Defect in cytosolic Neu2 sialidase abrogates lipid metabolism and impairs muscle function in vivo
    Mijung Oh et al, 2022, Sci Rep CrossRef
  57. Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
    Sahil Khanna et al, 2022, Journal of Nutrition and Metabolism CrossRef
  58. Prevention of Higher Triglycerides, Malondialdehyde, And Fatty Liver Disease Using the Ethanolic Extract of Sea Lettuce (Ulva lactuca) in Male Wistar Rats (Rattus Norvegicus)
    Putu Austin Widyasari Wijaya et al, 2022, Curr Res Nutr Food Sci CrossRef
  59. The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis
    Jing Wang et al, 2022, Nutrients CrossRef
  60. Utility of 99mTc-Sestamibi Heart/Liver Uptake Ratio in Screening Nonalcoholic Fatty Liver Disease During Myocardial Perfusion Imaging
    Ghazal Norouzi et al, 2022, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  61. Association between Fasting and Postprandial Levels of Liver Enzymes with Metabolic Syndrome and Suspected Prediabetes in Prepubertal Children
    Katarzyna Bergmann et al, 2023, IJMS CrossRef
  62. Mechanisms linking hypertriglyceridemia to acute pancreatitis
    Lóránd Kiss et al, 2023, Acta Physiologica CrossRef
  63. A comparative study to determine the effects of breed and feed restriction on glucose metabolism of chickens
    Pengfei Du et al, 2023, Animal Nutrition CrossRef
  64. Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis
    Ehsan Amini-Salehi et al, 2023, Hepat Mon CrossRef
  65. Circulating triglycerides are associated with human adipose tissue DNA methylation of genes linked to metabolic disease
    Tina Rönn et al, 2023 CrossRef
  66. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
    Menooa Ebrahimi et al, 2023, Lipids Health Dis CrossRef
  67. MSC−sEV Treatment Polarizes Pro−Fibrotic M2 Macrophages without Exacerbating Liver Fibrosis in NASH
    Bin Zhang et al, 2023, IJMS CrossRef
  68. The Role of Platelets in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Therapeutics.
    Malladi Navya et al, 2023, Prostaglandins & Other Lipid Mediators CrossRef
  69. Gypenosides and capsaicinoids in combination ameliorates high-fat-diet- induced rat hyperlipidemia via the PPARγ-LXRα-ABCA1/ABCG1 pathway
    Fangbo Zhang et al, 2023, Journal of Functional Foods CrossRef
  70. Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration
    Sung Eun Kim et al, 2023, Sci Rep CrossRef
  71. Artificial Pasture Grazing System Attenuates Lipopolysaccharide-Induced Gut Barrier Dysfunction, Liver Inflammation, and Metabolic Syndrome by Activating ALP-Dependent Keap1-Nrf2 Pathway
    Qasim Ali et al, 2023, Animals CrossRef
  72. Nutrition assessment and MASH severity in children using the Healthy Eating Index
    Ajay Kumar Jain et al, 2023 CrossRef
  73. Homeostatic Model Assessment of Insulin Resistance as a Potential Screening Test for Non-Alcoholic Fatty Liver Disease in Korean Adults without Diabetes
    Hyejung Lee et al, 2023, Korean J Fam Pract CrossRef
  74. The effects of L-carnitine supplementation on lipid profiles in adults: A systematic review and dose-response meta-analysis
    Sina Raissi Dehkordi et al, 2023, PharmaNutrition CrossRef
  75. Compromised very-low density lipoprotein induced polyunsaturated triglyceride accumulation in N-nitrosodiethylamine-induced hepatic steatosis
    Xuerao Lan et al, 2024, Food and Chemical Toxicology CrossRef